Alkermes (NASDAQ: ALKS) exec lines up $423K stock sale
Alkermes (ALKS) officer Craig C. Hopkinson filed a Rule 144 notice for potential sales of 9,000 ordinary shares, valued at $422,874.27. The shares include those from an employee stock option exercise, performance share award vesting, and restricted stock unit vesting. Alkermes had 167,763,272 ordinary shares outstanding as of 09/01/2026.
How this was made
The 30-second read
Why it matters
The disclosed sale adds a modest amount of shares to the market, likely causing negligible price movement.
Market read
Routine insider sale with limited trading impact.
What to watch
Potential tax planning or liquidity needs unrelated to company performance.
Background
Rule 144 filings allow insiders to sell restricted shares after meeting holding periods, often signaling upcoming supply.
Ticker impact
Alkermes officer filed a Rule 144 notice to sell 9,000 shares worth about $423K, indicating potential new supply to the market.
Minor short-term dip, limited to a few basis points.
The sale size is small relative to float and typical for routine insider transactions.
Market effects
Minimal impact on the biotech sector; similar insider sales are common.
No significant regional effect.
Limited to Alkermes investors.
Counterpoint
The sale may be a signal of insider confidence if the shares are being sold at a premium.
Key entities
- OfficerCraig C. Hopkinson
Alkermes officer filing the Rule 144 notice.
